Eledon Pharmaceuticals, Inc. Cash
Eledon Pharmaceuticals, Inc. (ELDN) had Cash of $8.76 million as of 2020-06-30, per its 10-Q filed 2020-08-14.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2020-08-14
- 2020-06-30: Cash $8.76M.
- 2020-03-31: Cash $11.79M.
- 2019-12-31: Cash $8.79M.
- 2019-09-30: Cash $10.81M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2020-06-30 | $8.76M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $11.79M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $8.79M 10-Q · filed 2020-08-14 | |
| 2019-09-30 | $10.81M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $13.70M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $9.06M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $12.97M 10-Q · filed 2019-11-13 | $13.00M 10-K · filed 2019-03-28 |
| 2018-09-30 | $16.32M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $19.19M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $22.52M 10-Q · filed 2018-05-11 | |
| 2017-12-31 | $17.23M 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |